Navigation Links
New Drug Could Reduce Stroke Complications

Glasgow University researchers have said that a new drug holds considerable promise in cutting down the complications that arise after a stroke. The reserachers arrived at this conclusion after testing this drug// on 1,700 patients in 154 hospitals across the world.

The treatment, called NXY-059, reduces the amount of brain damage that occurs just after the patient has suffered a clot-related stroke, which is caused by a blockage in the blood vessels that supply the brain. Complications of such a stroke include facial weakness, arm weakness and speech problems. In the current study, patients who were admitted into the hospital within six hours of developing a stroke were examines and 50 percent of them received normal fluids, while the others received fluids as well as NXY-059. Patients who were given this new drug were more likely to have made a full recovery from stroke after three months, said lead researcher Professor Kennedy Lees. Their odds of avoiding disability were about 20% better if they were given NXY-059. This trial opens up new horizons for treatment of one of the most important conditions affecting our society. He added that the availability of the drug meant that patients could be given treatment three hours after the symptoms of a stroke developed. The reserachers also said that this drug could also reduce the bleeding associated with clot dissolving drugs. Stroke is one of the leading causes of death and disability worldwide and this treatment has opened up new avenues in the treatment of the condition. Commenting on the new study, David Clark, chief executive of the charity Chest said, About half of all stroke survivors have some significant disability, so anything which reduces this disability is potentially of great benefit, especially as this has the potential to be developed as a routine treatment in all stroke units.


'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Nasal Spray Could Take Drugs Direct to Brain.
3. Nasal Spray Could Take Drugs Directly to Brain
4. Oxygen Usage During Exercise Could Indicate Heart Problems
5. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
6. Anger Could Be Linked To Weight Gain
7. A Seizure Late In Life Could be A Stroke Warning
8. New Findings Could Reduce The Extent Of Spinal Cord Injuries
9. Could There Be A Link Between Famine and Breast Cancer ?
10. Bone Marrow Cells Could Yield A New Lease of Life
11. New Hair in 15 Days Could Now Be A Possibility Say Researchers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... August 18, 2017 , ... More than 20,000 pairs of ... Congo (DRC) thanks to an ambitious venture that conjoined the passions of an NBA ... support of the Liberty community. These shoes will save lives from the rampant infections ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces the launch ... lifestyles and highlighting the importance of proactive eye and ear health. The campaign ... latest innovations in hearing aid technology. , In this issue, the National ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... handling handheld devices. Through an educational webinar, they will present the line of ... chance to learn how easy you can automate everyday pipetting tasks. , Ideal ...
(Date:8/18/2017)... ... 2017 , ... Radabaugh & Associates, a family managed agency ... West Virginia, is embarking on a cooperative charity effort with the Chestnut Mountain ... Chestnut Mountain Ranch (CMR) is a Christ-centered boarding school for young men offering ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Brian Gifford Agency, an ... is campaigning in support of Campagna Academy in a charity drive to provide for ... Boys’ Town of Indiana,” Campagna Academy is a nonprofit organization that has offered critical ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... AccuGenomics, Inc., a diagnostic company based in ... the company has provided an AccuKit to the HIV ... Chapel Hill and to Qura Therapeutics for evaluation in ... HIV reservoir and viral expression in human CD4+ T ... Center is a joint initiative between the University of ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
(Date:8/7/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest ... June 30, 2017.  All comparisons, unless otherwise noted, are to ... Second Quarter 2017 Highlights include: ... an increase of 3.5% Total prescriptions dispensed ... of 7.5% versus 7.6% Gross profit ...
Breaking Medicine Technology: